---
title: "DIAZ REINALDO M — Ownership Dossier"
canonical: https://whiteintel.dev/entity/6fde644f-ebe5-5b3c-9944-a8c00a454a30
json: https://whiteintel.dev/api/public/dossier/6fde644f-ebe5-5b3c-9944-a8c00a454a30
identifier: sec:0001250086
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# DIAZ REINALDO M

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001250086`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/6fde644f-ebe5-5b3c-9944-a8c00a454a30  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/6fde644f-ebe5-5b3c-9944-a8c00a454a30  

## Ownership & control

### Holdings / subsidiaries

- **MEGABIOS CORP** (director) — https://whiteintel.dev/entity/67f6e7d2-c77d-5beb-a314-92b45bde85af
- **Lexeo Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/200fe036-dc2e-55ce-ae90-6f63aefe68ea
- **Inozyme Pharma, Inc.** (director) — https://whiteintel.dev/entity/7fb05f43-aaa9-5234-a3e0-9d958c25cded

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **DIAZ REINALDO M**. Human view: https://whiteintel.dev/entity/6fde644f-ebe5-5b3c-9944-a8c00a454a30 · Structured JSON: https://whiteintel.dev/api/public/dossier/6fde644f-ebe5-5b3c-9944-a8c00a454a30._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._